ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 937

Distal Interphalangeal Joint Erosions Assessed By HR-pQCT in Patients with Psoriatic Onycholysis

Axel Patrice VILLANI1, Stéphanie Boutroy2, Hubert Marotte Sr.3, Loïs Barets4, Marie-Christine Carlier5, Roland Chapurlat6, Denis Jullien1 and Cyrille B Confavreux7, 1Dermatology, Hôpital Edouard Herriot, Dermatology department, Lyon I University, Lyon, France, 2Lyon I University, Inserm UMR1033, Lyon, France, 3CHU de St Etienne, Service de rhumatologie, St Etienne, France, 4Rheumatology, Hôpital Edouard Herriot, Lyon, France, 5Biochemistry, Hôpital Edouard Herriot, Lyon, France, 6Rheumatology, Hôpital Edouard Herriot, Hospices Civils de Lyon, University of Lyon, Lyon, France, 7Hôpital Edouard Herriot, Hospices Civils de Lyon, University of Lyon, Lyon, France

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Bone, HR-pQCT, psoriasis and psoriatic arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 13, 2016

Title: Imaging of Rheumatic Diseases I: Advanced Imaging in RA and Spondyloarthritides

Session Type: ACR Concurrent Abstract Session

Session Time: 2:30PM-4:00PM

Background/Purpose: A third of cases of skin psoriasis are complicated by potentially incapacitating psoriatic arthritis (PsA). Nail psoriasis, especially onycholysis, is present in more than 70% of PsA and the risk of developing PsA is significantly higher in patients with nail involvement (OR = 2.24; 95% CI [1.26-3.98]) (Wilson FC. Arthritis Rheumatism 2009). In this study, we wanted to test the hypothesis that onycholysis, in patients without PsA, may be a potential clinical marker of subclinical distal pathogenic enthesopathy and thus may present early bone microstructural alterations of the distal interphalangeal joint.

Methods: We compared bone microstructural damages (erosions, osteophytes) of the distal interphalangeal joint using High Resolution Peripheral Quantitative Computed Tomography imaging HR-pQCT (XtremCT Scanco, Switzerland®) in patients with psoriatic onycholysis without PsA (ONY) and in patients with cutaneous psoriasis only without PsA or nail psoriasis (PsO). We used, as reference for bone features, patients with peripheral psoriatic arthritis (PsA) and healthy gender/age-matched controls. Ultrasonography of the target distal interphalangeal joint was used to assess enthesopathy (finger extensor tendon thickness), synovitis, and nail apparatus (nail plate and matrix).

Results: Between 2013 and 2016, 80 patients were recruited in the four following groups (20 per group): controls, ONY, PsO and PsA. Mean±SD age of the participants was 45.7±4.3 years. Nail plate thickness, matrix and finger extensor tendon thickness were increased in ONY versus PsO patients. Erosions and synovitis were observed in respectively 8.3% and 4.1% of ONY patients but never in PsO patients. By HR-pQCT, ONY patients were associated with a mean number of 3.6±0.77 erosions of the distal interphalangeal joint versus only 0.21±0.1 in PsO patients (p=0.035). PsA patients presented several V-shaped, Omega-shaped, U-shaped erosions and osteophytes.

Conclusion: We describe for the first time the existence of bone erosions in interphalangeal distal joints of patients with psoriatic onycholysis. These findings support the pathogenic role of enthesopathy in joint involvement of PsA. These data underly the potential severity of onycholysis compared to isolated cutaneous psoriasis only. Onycholysis may be considered as a clinical marker for patients with psoriasis who have an increased risk of joint destruction.


Disclosure: A. P. VILLANI, None; S. Boutroy, None; H. Marotte Sr., None; L. Barets, None; M. C. Carlier, None; R. Chapurlat, None; D. Jullien, None; C. B. Confavreux, None.

To cite this abstract in AMA style:

VILLANI AP, Boutroy S, Marotte H Sr., Barets L, Carlier MC, Chapurlat R, Jullien D, Confavreux CB. Distal Interphalangeal Joint Erosions Assessed By HR-pQCT in Patients with Psoriatic Onycholysis [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/distal-interphalangeal-joint-erosions-assessed-by-hr-pqct-in-patients-with-psoriatic-onycholysis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/distal-interphalangeal-joint-erosions-assessed-by-hr-pqct-in-patients-with-psoriatic-onycholysis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology